Kawasaki syndrome or Kawasaki disease is a common name for lymph node syndrome and mucocutaneous lymph node syndrome, also known as MLNS.
The name is given by Dr. Kawasaki, who described the disease in 1967.Kawasaki syndrome is known worldwide for affecting children, who mostly fall under the age of 5 years. The skin, walls of blood vessels, mucous membranes and lymph nodes get adversely affected by the disease. Effect of the disease on heart of the children makes the condition worse, and this gives rise to aneurysmal dilations.
Only in a short period of 6 weeks, the syndrome can touch the level of mortality rate of 1 percent if the proper treatment is not provided. With treatment, the mortality rate is around 0.01 percent.
The cause of Kawasaki disease is said to have originated from environmental, genetic as well as infectious factors. Although no particular cause is still known, recent theories supports the immunological cause.
A report submitted by Children’s Hospital Boston shows the relation of dirt and stagnant water with the disease.
The disease is generally handled together by specialists in cardiology and infectious disease.
IVIG or intravenous immunoglobulin treatment is one of the best known ways of treating the affected patients. Other method of treatment is salicylate therapy or aspirin. The patient is given a high amount of aspirin followed by a constant decrease if the patient exhibits a better health condition. When other treatment methods fail to give a better result, corticosteroids are also used.
Affected children should be provided good care with continuous and periodic radiology tests to ascertain the any complications.
More Articles :